181 related articles for article (PubMed ID: 1492840)
1. Fluorenone and benzophenone 1,4-dihydropyridine derivatives with cardiodepressant activity.
Rampa A; Budriesi R; Bisi A; Chiarini A; Valenti P
Arzneimittelforschung; 1992 Nov; 42(11):1284-7. PubMed ID: 1492840
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and pharmacological profile of some chloroxanthone-1, 4-dihydropyridine derivatives.
Bisi A; Budriesi R; Rampa A; Fabbri G; Chiarini A; Valenti P
Arzneimittelforschung; 1996 Sep; 46(9):848-51. PubMed ID: 8876931
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and cardiodepressant activity of dialkyl 1,4-dihydro-2,6-dimethyl-4-(pentatomic-heteroaryl)-3,5-pyridine-dicarbo xylates. 2.
Baraldi PG; Garuti L; Leoni A; Cacciari B; Budriesi R; Chiarini A
Drug Des Discov; 1993; 10(4):319-29. PubMed ID: 8148471
[TBL] [Abstract][Full Text] [Related]
4. SAR studies in the field of Ca-antagonists: 2-substituted 1,4-dihydropyridines with a xanthone backbone.
Bisi A; Budriesi R; Chiarini A; Rampa A; Valenti P
Farmaco; 1993 Nov; 48(11):1491-502. PubMed ID: 8110362
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationship studies of xanthone and fluorenone-1,4-dihydropyridine-5-phosphonates.
Budriesi R; Rampa A; Bisi A; Fabbri G; Chiarini A; Valenti P
Arzneimittelforschung; 1996 Apr; 46(4):374-7. PubMed ID: 8740081
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship studies in the field of calcium antagonists. Xanthone 1,4-dihydropyridines bearing a 2,3-lactone ring.
Rampa A; Budriesi R; Bisi A; Fabbri G; Barili PL; Chiarini A; Valenti P
Arzneimittelforschung; 1995 Sep; 45(9):957-62. PubMed ID: 7488312
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and cardiovascular properties of fluorenyl derivatives related to verapamil.
Romanelli MN; Teodori E; Scapecchi S; Dei S; Budriesi R; Chiarini A
Farmaco; 1991 Oct; 46(10):1121-38. PubMed ID: 1815578
[TBL] [Abstract][Full Text] [Related]
8. 4-heterotricyclic substituted 1,4-dihydropyridines with a potent selective bradycardic effect.
Rampa A; Chiarini A; Bisi A; Budriesi R; Valenti P
Arzneimittelforschung; 1991 Jul; 41(7):705-9. PubMed ID: 1772458
[TBL] [Abstract][Full Text] [Related]
9. Coumarin 1,4-dihydropyridine derivatives.
Valenti P; Rampa A; Budriesi R; Bisi A; Chiarini A
Bioorg Med Chem; 1998 Jun; 6(6):803-10. PubMed ID: 9681146
[TBL] [Abstract][Full Text] [Related]
10. Xanthone 1,4-dihydropyridine derivatives with a potent selective bradycardic effect.
Valenti P; Chiarini A; Gasperi F; Budriesi R
Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):122-5. PubMed ID: 2334451
[TBL] [Abstract][Full Text] [Related]
11. Negative inotropic and chronotropic activity of calcium channel ligands possessing a xanthone 1,4-dihydropyridine backbone.
Chiarini A; Rampa A; Bisi A; Budriesi R; Valenti P
Arzneimittelforschung; 1992 Jun; 42(6):797-801. PubMed ID: 1329778
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and cardiovascular properties of furazanyl-1,4-dihydropyridines and of furoxanyl analogues.
Gasco AM; Fruttero R; Sorba G; Gasco A; Budriesi R; Chiarini A
Arzneimittelforschung; 1992 Jul; 42(7):921-5. PubMed ID: 1418057
[TBL] [Abstract][Full Text] [Related]
13. Long-acting dihydropyridine calcium antagonists. 3. Synthesis and structure-activity relationships for a series of 2-[(heterocyclylmethoxy)methyl] derivatives.
Alker D; Campbell SF; Cross PE; Burges RA; Carter AJ; Gardiner DG
J Med Chem; 1989 Oct; 32(10):2381-8. PubMed ID: 2795609
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and pharmacological characterization of some benzazepinone derivatives.
Budriesi R; Rampa A; Bisi A; Fabbri G; Chiarini A; Valenti P
Arzneimittelforschung; 1995 Mar; 45(3):234-9. PubMed ID: 7741775
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of some 1,4-dihydropyridine derivatives and their calcium antagonistic activity.
Safak C; Sahin I; Sunal R
Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):119-22. PubMed ID: 2334450
[TBL] [Abstract][Full Text] [Related]
16. Calcium channel blocking and positive inotropic activities of ethyl 5-cyano-1,4-dihydro-6-methyl-2-[(phenylsulfonyl)methyl]-4-aryl-3- pyridine-carboxylate and analogues. Synthesis and structure-activity relationships.
Sircar I; Gregor EK; Anderson KR; Haleen SJ; Shih YH; Weishaar RE; Steffen RP; Pugsley TA; Taylor MD
J Med Chem; 1991 Jul; 34(7):2248-60. PubMed ID: 2066997
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of a new class of 1,4-dihydropyridines having a hydroxamic ester group in position 3 with a potential calcium antagonistic activity.
Inglesi M; Nicola M; Magnetti S
Farmaco; 1990 Dec; 45(12):1327-40. PubMed ID: 2090142
[TBL] [Abstract][Full Text] [Related]
18. Cardiac versus vascular effects of a new dihydropyridine derivative, CV-4093. In vitro comparison with other calcium antagonists.
Nakaya H; Hattori Y; Nakao Y; Kanno M
Eur J Pharmacol; 1988 Jan; 146(1):35-43. PubMed ID: 3350058
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing dichloroimidazolyl substituents.
Amini M; Golabchifar AA; Dehpour AR; Pirali HM; Shafiee A
Arzneimittelforschung; 2002; 52(1):21-6. PubMed ID: 11838270
[TBL] [Abstract][Full Text] [Related]
20. Long acting dihydropyridine calcium antagonists. 2. 2-[2-Aminoheterocycloethoxy]methyl derivatives.
Arrowsmith JE; Campbell SF; Cross PE; Burges RA; Gardiner DG
J Med Chem; 1989 Mar; 32(3):562-8. PubMed ID: 2918502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
